** Shares of medical equipment maker Revvity RVTY.N rise 6% to $110.40 in extended trading
** Expects 2025 adjusted EPS to exceed its forecast range of $4.90 to $5 given in October
** Sees preliminary Q4 revenue of $772 million vs estimates of $760.3 million - data compiled by LSEG
** RVTY will report Q4 and full-year results on February 2
** Stock was down 13% in 2025
(Reporting by Koyena Das in Bengaluru)
((koyena.das@thomsonreuters.com))